RO87010B1 - Intensified anticolinergic medicinal preparation - Google Patents

Intensified anticolinergic medicinal preparation

Info

Publication number
RO87010B1
RO87010B1 RO111313A RO11131383A RO87010B1 RO 87010 B1 RO87010 B1 RO 87010B1 RO 111313 A RO111313 A RO 111313A RO 11131383 A RO11131383 A RO 11131383A RO 87010 B1 RO87010 B1 RO 87010B1
Authority
RO
Romania
Prior art keywords
anticolinergic
intensified
medicinal preparation
intoxication
irreversible
Prior art date
Application number
RO111313A
Other languages
Romanian (ro)
Other versions
RO87010A2 (en
Inventor
Victor Voicu
Alexandru Stoian Ionescu
Lelia Antoniu
Merilena Jiguidi
Constantin Miu
Original Assignee
Ministerul Apararii Nationale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ministerul Apararii Nationale filed Critical Ministerul Apararii Nationale
Priority to RO111313A priority Critical patent/RO87010B1/en
Publication of RO87010A2 publication Critical patent/RO87010A2/en
Publication of RO87010B1 publication Critical patent/RO87010B1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Inventia se refera la un preparat medicamentos anticolinergic potentat, care în scopul tratamentului efectelor colinergice centrale si periferice din intoxicatia cu anticolinesterazice ireversibile si reversibile, este constituit din 0,08...0,15% atropina sulfat, 0,03...0,5% scopolamina bromhidrat 2,0...2,5% imipramina clorhidrat si apa bidistilata pîna la 100 ml.The invention relates to a potent anticholinergic drug which in order to treat the central and peripheral cholinergic effects of the irreversible and reversible anticholinesterase intoxication consists of 0.08 ... 0.15% atropine sulfate, 0.03 ... 0 , 5% scopolamine hydrobromide 2.0 ... 2.5% imipramine hydrochloride and water distilled to 100 ml.

RO111313A 1983-06-17 1983-06-17 Intensified anticolinergic medicinal preparation RO87010B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RO111313A RO87010B1 (en) 1983-06-17 1983-06-17 Intensified anticolinergic medicinal preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RO111313A RO87010B1 (en) 1983-06-17 1983-06-17 Intensified anticolinergic medicinal preparation

Publications (2)

Publication Number Publication Date
RO87010A2 RO87010A2 (en) 1985-05-20
RO87010B1 true RO87010B1 (en) 1985-05-31

Family

ID=20113239

Family Applications (1)

Application Number Title Priority Date Filing Date
RO111313A RO87010B1 (en) 1983-06-17 1983-06-17 Intensified anticolinergic medicinal preparation

Country Status (1)

Country Link
RO (1) RO87010B1 (en)

Also Published As

Publication number Publication date
RO87010A2 (en) 1985-05-20

Similar Documents

Publication Publication Date Title
HUP9800794A2 (en) The use of (S)-oxybutynin and (S)-desethyloxybutynin for the production of pharmaceutical preparations for the treatment of urinary incontinence and the preparation of the compounds
CA2012876A1 (en) Use of 5-methyltetrahydrofolic acid and 5-formyltetrahydrofolic acid in the treatment of organic mental disturbances
IL72684A (en) Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs
IL152659A (en) Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer
DK201788D0 (en) DISINFECTIVE COMPOSITIONS AND PROCEDURES FOR THEIR PREPARATION AND USE
ES8706670A1 (en) a process and intermediates for their preparation and their use as medicaments.
BR9609971A (en) Preparation of pharmaceutical combinations containing erythropoietin and iron preparations
RO87010B1 (en) Intensified anticolinergic medicinal preparation
DK0585314T3 (en)
BR9714632A (en) Pharmaceutical combination preparation, process for the production of pharmaceutical combination preparations, use of erythropoietin and iron preparations, and pharmaceutical packaging unit
HRP940210A2 (en) New imidazoloquinoxalinones their production and use
GR3020575T3 (en) New 2-amino-5-cyano-1,4-dihydropyridines, process for their preparation and use in pharmaceutical compositions
FR2691149B1 (en) NOVEL THIOCHROMANIC COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
IL87234A (en) Optical isomers of 2-methylspiro(1,3-oxathiolane-5,3')quinuclidine,their preparation and pharmaceutical compositions containing them
MX9200607A (en) 9-AMINO TETRA HYDRO ACRIDINES AND RELATED COMPOUNDS, A PROCEDURE FOR THEIR PREPARATION AND USE AS MEDICINES.
YU23490A (en) PHARMACEUTICAL PREPARATION FOR TREATMENT OF TONSILITIS
EP0349589A4 (en) PHARMACOLOGICALLY ACTIVE CHOLINERGIC COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF.
BE902055A (en) PHARMACEUTICAL PREPARATIONS.
ATE227981T1 (en) CAPTOPRIL TABLETS
ES8801267A1 (en) 4H-pyrimido[2,1-a]isoquinolin-4-one derivatives.
JPS6438073A (en) Novel derivative of tetrahydropyridine, manufacture and intermediate, use as drug and medicinal composition
FR2360313A1 (en) USEFUL PHARMACEUTICAL COMPOSITIONS ESPECIALLY FOR THE TREATMENT OF SEBORRHEA
Fisher et al. Lithic raw material economies in late glacial and early postglacial Europe
RO93806B1 (en) Antiasthmatical medicinal tablets for pedriatic use
NO993126D0 (en) Use of benzoylalkyl-1,2,3,6-tetrahydropyridines